Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 1190307 88 0. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107868105A reveals advanced recrystallization for Sofosbuvir intermediates. Achieves 99.8% purity with improved yield for reliable pharmaceutical supply chains.
Novel reduction method for Sofosbuvir intermediate avoiding column chromatography. High yield, scalable process for API manufacturing.
Patent CN106146433A reveals a streamlined synthesis for Sofosbuvir intermediates offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN107245064A details safer borohydride reduction for Sofosbuvir intermediates. Achieve high purity and cost reduction in API manufacturing with scalable recovery methods.